Allogene Therapeutics Stock (NASDAQ: ALLO) stock price, news, charts, stock research, profile.
You can purchase shares of Allogene Therapeutics (NASDAQ:ALLO) through any online brokerage.
Other companies in Allogene Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Voyager Therapeutics (NASDAQ:VYGR), Celcuity (NASDAQ:CELC), Korro Bio (NASDAQ:KRRO) and Sage Therapeutics (NASDAQ:SAGE).
Allogene Therapeutics has a consensus price target of $13.31.
The stock price for Allogene Therapeutics (NASDAQ: ALLO) is $2.0201 last updated December 17, 2024 at 6:19 PM EST.
There are no upcoming dividends for Allogene Therapeutics.
Allogene Therapeutics’s Q4 earnings are confirmed for Thursday, March 13, 2025.
There is no upcoming split for Allogene Therapeutics.
Allogene Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.